ATRC Insider Trading Activity and SEC Form 4 Filings
ATRC insider trading summary
Over the past 12 months, insiders at AtriCure, Inc. (ATRC) reported 16 sales worth $4.6M by 8 insiders and no open-market purchases on SEC Form 4. Net insider selling was $4.6M.
Latest ATRC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Salvatore Privitera | Chief Technical Officer | Sell | $546K (8,404 @ $65.00) |
| Sep 23, 2026 | Salvatore Privitera | Chief Technical Officer | Sell | $271K (4,519 @ $60.00) |
| Sep 11, 2026 | Regina E Groves | Director | Sell | $288K (5,313 @ $54.22) |
| Sep 2, 2026 | Salvatore Privitera | Chief Technical Officer | Sell | $408K (7,763 @ $52.50) |
| Aug 24, 2026 | Karl S. Dahlquist | Chief Legal Officer | Sell | $458K (9,370 @ $48.89) |
| Aug 5, 2026 | Karen Prange | Director | Sell | $138K (3,564 @ $38.80) |
| Aug 5, 2026 | Maggie Yuen | Director | Sell | $134K (3,500 @ $38.42) |
| Jul 29, 2026 | Justin J Noznesky | Chief Mktg & Strategy Officer | Sell | $240K (6,182 @ $38.80) |
| Jul 28, 2026 | Vinayak Doraiswamy | Chief Scientific Officer | Sell | $233K (6,000 @ $38.88) |
| Jul 28, 2026 | Sven Wehrwein | Director | Sell | $946K (25,000 @ $37.84) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.